Water balance in the Brattleboro rat: considerations for hormone replacement therapy.
D000818:Animals; D001127:Arginine Vasopressin / Q000627:therapeutic use; D001834:Body Water / Q000502:physiology; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000503:physiopathology; D004231:Diuresis / Q000187:drug effects; D004326:Drinking; D007031:Hypothalamus / Q000503:physiopathology; D009994:Osmolar Concentration; D010904:Pituitary Gland, Posterior / Q000503:physiopathology; D051381:Rats; D011910:Rats, Brattleboro / Q000502:physiology*; D011922:Rats, Mutant Strains / Q000502:physiology*; D013894:Thirst / Q000502:physiology; D014667:Vasopressins / Q000008:administration & dosage / Q000502:physiology / Q000627:therapeutic use*; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy* / Q000503:physiopathology
D014667:Vasopressins; D001127:Arginine Vasopressin; D003894:Deamino Arginine Vasopressin